Equazen ® Reaffirms Its Commitment to Uncompromising Quality and Sustainability in Omegas Supplements
26.6.2025 08:00:00 CEST | Business Wire | Press Release
SFI Health™EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, highlights today its ongoing commitment to delivering the highest standard of quality for Equazen®, the company’s global science-based food supplement brand designed to nourish, enhance and support the brain’s potential.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625554235/en/
Equazen® continues to set the benchmark for excellence at every step of the value chain
At SFI Health™, quality is more than a requirement—it is a mission. The company is committed to enhancing people’s well-being by developing natural supplements that combine passion for nature-based healthcare, science, state-of-the-art production standards and sustainability, from ingredient sourcing to the final product reaching the patient.
In particular, with over 25 years of trust built across multiple markets, Equazen®'s excellence is built on five core pillars:
- Ingredients Sourcing: Equazen®’s story begins in the sea, with responsibly sourced fish oil rich in essential Omega-3 fatty acids EPA and DHA, paired with cold-pressed evening primrose and borage seeds oils for Omega-6 (GLA). Every ingredient is carefully selected from certified suppliers, processed using validated methods ensuring purity and safety as well as full traceability in compliance with European Pharmacopoeia regulations. Besides, Equazen® suppliers are part of the IFFO, the international marine ingredients organization, promoting responsible sourcing and high-quality manufacturing in the industry of fish oil.
- Manufacturing & Supply Chain: Equazen® is produced under strict GMP standards, with each fish oil batch undergoing rigorous quality testing. All manufacturers adhere to recognized food safety systems, including HACCP and FDA registration. The supply chain is equally controlled—from packaging to transport—to protect product integrity till it reaches consumers. In addition, Equazen®’s suppliers are members of GOED (Global Organization for EPA and DHA Omega-3s), a respected international association setting high ethical and quality standards for the Omega-3 industry.
- Science-backed innovation: Equazen® products feature a unique and carefully balanced combination of essential fatty acids (Omega 3 and Omega 6), designed to support cognitive needs. Since its inception in 1999, Equazen® products’ benefits for the human brain have been proven in over 15 pre-clinical and clinical investigations. In addition, ongoing collaborations with global experts and research institutions further strengthen the scientific foundation.
- Customer focus: Understanding and responding to consumer needs is key to Equazen®’s success. Feedback from parents, healthcare professionals, and consumers shapes product development and ongoing support. The brand also offers personalized guidance and educational resources to optimize usage.
- Sustainability: Equazen® also prioritizes environmental responsibility with sustainable production processes designed to minimize environmental impact. Its fish oil is sourced from regulated, sustainable fisheries and is a by-product of the fishmeal industry—ensuring no additional fish are caught for production. In addition, Equazen® fish oils are certified by Friends of the Sea®, a globally recognized independent body guaranteeing responsible sourcing, full traceability, and environmental stewardship.
“Our mission with Equazen® is to provide natural supplements that parents and caregivers can trust to support cognitive needs and the health of human brain,” said Matthew Brabazon, General Manager at SFI Health™ EMEA. “This is made possible only through ethical sourcing, advanced manufacturing, and robust scientific validation.”
As market demands evolve, Equazen® remains dedicated to pushing quality standards further at every step of the value chain to offer best-in-class solutions for optimal cognitive health. Consumers can trust that every product reflects a passion for health, innovation, and sustainability.
About SFI Health™
SFI Health™ is a global leader in natural healthcare, specialized in the design, development and commercialization of clinically researched products in the areas of microbiome, cognition and wellbeing.
Guided by the belief in the healing potential of natural products, SFI Health™ combines a rigorous pharma-based approach with the benefits of naturally sourced solutions.
An extensive network of trusted business partners enables the company, headquartered in Australia, to market its own brands, reaching consumers in over 50 countries. The EMEA SFI Health™ regional office in Lugano, Switzerland, manages commercial operations across Europe, Middle East and Africa.
SFI Health™ is committed to fostering confidence in natural healthcare by sharing state-of-the-art research, technical expertise and comprehensive sales & marketing resources with consumers, healthcare professionals and partners worldwide.
For more information, go to sfihealth.com or follow us SFI Health on LinkedIn.
About Equazen®
Equazen® is a science-based globally branded food supplement designed and studied to help nourish, enhance, and support the human brain’s potential across all life stages.
Each product of the Equazen® range contains a balanced unique combination of essential fatty acids (Omega-3 and Omega-6), which has been clinically proven for more than 20 years to assist with learning capabilities, concentration and healthy brain development.
Equazen® is available in multiple pharmaceutical formats and sizes to support optimal cognitive functions from infants to teenagers.
Currently marketed in 30 countries globally, Equazen® is widely recommended by healthcare professionals and trusted by families for the last 25 years.
Equazen® aims to advance human health naturally, delivering expertly formulated products that empower individuals to reach their cognitive potential.
For more info visit www.equazen.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250625554235/en/
Contacts
For more information
SFI Health™ EMEA Contact
Elisabetta Bianchi
e-mail address: elisabetta.bianchi@sfihealth.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Empire State Building Observation Deck Hosts Annual Run-Up, Presented by NYU Langone Health and Powered by Merrell7.10.2026 04:25:00 CEST | Press Release
The Empire State Building (ESB) hosted the 48th Annual Empire State Building Observation Deck Run-Up, presented by NYU Langone Health and powered by Merrell. In several designated heats, more than 200 runners from across the world raced up the building’s 1,576 stairs to reach the finish line on the iconic 86th Floor Observation Deck. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261006766024/en/ The Empire State Building Observation Deck Hosts Annual Run-Up, Presented by NYU Langone Health and Powered by Merrell “Athletes gather from around the globe to participate in the Empire State Building Observation Deck Run-Up, the world’s preeminent tower race,” said Tony Malkin, chairman and CEO of Empire State Realty Trust. “We congratulate all who participated in this ultimate feat of endurance at Tripadvisor’s number one top attraction in the U.S.” Ryoji Watanabe of Japan took first place in the Men’s Elite heat with a time of 1
Phenom Adds Major Headline Speakers as IAMPHENOM Europe Approaches Sold-Out Status6.10.2026 15:30:00 CEST | Press Release
Phenom, the leader in applied AI built to redesign work operations for hiring faster, developing better and retaining longer, today announced the newest wave of speakers for IAMPHENOM Europe 2026, the only applied AI event dedicated to human resources taking place on 4-5 November in Paris, France. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261006714151/en/ Phenom announced the newest wave of speakers for IAMPHENOM Europe 2026, the only applied AI event dedicated to human resources taking place on 4-5 November in Paris, France. The two-day conference gives attendees what other HR events can’t: an inside look at AI agents already in production, automated workflows tailored to specific business contexts and the dramatic results they are already delivering. Across keynotes, customer sessions, hands-on experiences and peer networking with the continent’s top CHROs and HRIT decision-makers, guests can participate in discussion
European Firms Struggle to Keep Pace with Growing DSAR Demands, New Reveal Study Finds6.10.2026 15:00:00 CEST | Press Release
New research published today byReveal, the provider of integrated AI-native platforms spanning the dispute resolution lifecycle, found that large European organisations complete fewer than half of data subject access requests (DSARs) within the one-month deadline required under the General Data Protection Regulation (GDPR), a shortfall the study ties directly to a near-universal absence of purpose-built technology. Nearly nine in 10 organisations still run DSARs on manual or general-purpose workflows, with no dedicated tooling in place. The report, based on a survey of 213 legal and privacy professionals at large European enterprises, is the first of its kind to benchmark how organisations across the region are managing DSAR compliance at scale. The findings expose structural inconsistencies between how organisations perceive their DSAR processes and how those processes perform. Ninety percent of respondents said they are confident their process would withstand scrutiny from an Informa
Xsolla Shows Brand Owners How to Create Value for Video Players at Brand Licensing Europe With Rewarded Marketing6.10.2026 15:00:00 CEST | Press Release
Xsolla, a global commerce company, today announced it will be at Brand Licensing Europe 2026 at ExCeL London, October 6 to 8, to show brand owners how to engage with video game players by creating quest-based programs and value new users actually value. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261006443167/en/ Graphic: Xsolla Video games are one of the largest categories of entertainment spending in the world, yet most brands still treat the category as an experiment: a one-off promotional stunt or a single media buy, not a lasting engagement program. The traditional formats brands default to were never built for players. Interstitial pop-ups disrupt gameplay, banner ads go unnoticed, and in-game activations remain cumbersome and expensive to execute. The idea is already proven in games, where players have purchased, collected, and valued digital items for years. The relationship between players and games is built on t
New Global Survey Finds Majority of VMware Users Are Choosing Alternative Paths for Cost Control, Roadmap Flexibility and Better Support6.10.2026 15:00:00 CEST | Press Release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced findings from the 2026 IT Virtualization Survey – What’s Next for VMware Users, a new global survey of nearly 300 VMware user organizations conducted by Unisphere Research on behalf of Rimini Street. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261006014490/en/ New Global Survey Finds Majority of VMware Users Are Choosing Alternative Paths for Cost Control, Roadmap Flexibility and Better Support Cost Cited as the Number One Factor in Seeking Alternative VMware Solutions Key Findings: 90% of respondents said they are considering alternatives to VMware due to higher licensing costs, while 54% cited the end of perpetual license support as another reason to evaluate other options. The research shows that cost remains the leading driver of virtuali
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom